| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.067 | 0.07 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | 0.057 | 0.07 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | -0.063 | 0.07 |
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | -0.062 | 0.08 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | -0.055 | 0.08 |
| mRNA | KPT185 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.08 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.095 | 0.08 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.073 | 0.08 |
| mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.08 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | -0.1 | 0.08 |